Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country

PURPOSE: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non–small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide l...

Descripción completa

Detalles Bibliográficos
Autores principales: Poh, Mau Ern, How, Soon Hin, Ho, Gwo Fuang, Pang, Yong Kek, Hasbullah, Harissa H, Tho, Lye Mun, Muhamad Nor, Ibtisam, Lim, Bee Chiu, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Soon, Sing Yang, Tan, Justin Yu Kuan, Zainal Abidin, Muhammad Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844146/
https://www.ncbi.nlm.nih.gov/pubmed/36660237
http://dx.doi.org/10.2147/CMAR.S393729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844146/
https://www.ncbi.nlm.nih.gov/pubmed/36660237
http://dx.doi.org/10.2147/CMAR.S393729

Ejemplares similares